{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:17:15Z","timestamp":1784859435226,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      This study aimed to evaluate the diagnostic performance of [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-DOTATATE PET\/CT or PET\/MR in comparison to dynamic MR (dMR) in locating ACTH-secreting pituitary adenomas in Cushing's disease (CD). The utility of PET and MR semi-quantitative parameters was additionally explored as non-invasive biomarkers for tumor characterization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Aretrospective analysis was conducted in 14 patients with CD and 16 controls with ectopic ACTH syndrome. Surgical pathology and post-operative follow-up served as reference standard. All patients underwent [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-DOTATATE PET\/CT or PET\/MR, dMR; some also underwent [\n                      <jats:sup>18<\/jats:sup>\n                      F]F-FDG PET. Imaging interpretation included visual and semi-quantitative (SUVmax and ADCmin) assessment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-DOTATATE PET demonstrated a 100% sensitivity indetecting ACTH-secreting pituitary adenomas, superior to dMR with a sensitivity of 85.7%. [\n                      <jats:sup>18<\/jats:sup>\n                      F]F-FDG PET showed a sensitivity of 80%. Combining [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-DOTATATE PET with functional tests (high dose dexamethasone-suppression test and\/or inferior petrosal sinus sampling) achieved specificity up to 100%, whereas the specificity of PET alone was only 50% due to pituitary structural abnormalities. Semi-quantitative analysis confirmed significantly reduced [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-DOTATATE SUVmax and ADCmin in adenomas. Diagnostic efficacy ranked as follows: G-SUVmax from PET\/MR was optimal (AUC1.0), followed by ADCmin (AUC 0.96) and G-SUVmax from PET\/CT (AUC 0.87).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      G-SUVmax and ADCmin can be used as reliable diagnostic predictors. [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-DOTATATE PET\/MR may facilitate the preoperative localization of CD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1722034","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:22:54Z","timestamp":1769664174000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["[68Ga]Ga-DOTATATE PET\/CT and PET\/MR enhances the detection of pituitary ACTH-secreting adenomas in cushing\u2019s disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Zizhen","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Department of Nuclear Medicine, Fudan University Shanghai Cancer Center","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joim.13789","article-title":"Bilateral inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome: A reappraisal","volume":"296","author":"Valizadeh","year":"2024","journal-title":"J Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.11189","article-title":"The diagnosis and differential diagnosis of endogenous Cushing\u2019s syndrome","volume":"5","author":"Makras","year":"2006","journal-title":"Horm (Athens)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032249","article-title":"Diagnostic errors after inferior petrosal sinus sampling","volume":"89","author":"Swearingen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","first-page":"170","author":"Reincke","year":"2023"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101513","article-title":"New types of localization methods for adrenocorticotropic hormone-dependent Cushing\u2019s syndrome","volume":"35","author":"Senanayake","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00333","article-title":"Why we should still treat by neurosurgery patients with cushing disease and a normal or inconclusive pituitary MRI","volume":"104","author":"Cristante","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-013-0718-4","article-title":"Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation","volume":"27","author":"Kuyumcu","year":"2013","journal-title":"Ann Nucl Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14425","article-title":"Pre- and postoperative 68 Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours","volume":"94","author":"Tj\u00f6rnstrand","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-009-0180-4","article-title":"The diagnostic value of fused positron emission tomography\/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing\u2019s disease","volume":"12","author":"Alzahrani","year":"2009","journal-title":"Pituitary"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-01944-7","article-title":"CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing\u2019s disease","volume":"65","author":"Boyle","year":"2019","journal-title":"Endocrine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001085","article-title":"Utility of 11C-methionine and 18F-FDG PET\/CT in patients with functioning pituitary adenomas","volume":"41","author":"Feng","year":"2016","journal-title":"Clin Nucl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3171\/2009.7.JNS09285","article-title":"Usefulness of composite methionine-positron emission tomography\/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma","volume":"112","author":"Ikeda","year":"2010","journal-title":"J Neurosurg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2013.28.1.81","article-title":"Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions","volume":"28","author":"Seok","year":"2013","journal-title":"Kor J Intern Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000989","article-title":"Value of fluorine-18-fluorodeoxyglucose PET\/CT in localizing the primary lesion in adrenocorticotropic hormone-dependent Cushing syndrome","volume":"40","author":"Zhou","year":"2019","journal-title":"Nucl Med Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.191916","article-title":"PET\/MRI in the diagnosis of hormone-producing pituitary microadenoma: A prospective pilot study","volume":"59","author":"Wang","year":"2018","journal-title":"J Nucl Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000457","article-title":"Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy","volume":"39","author":"Zhao","year":"2014","journal-title":"Clin Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20200321","article-title":"Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study","volume":"93","author":"Conficoni","year":"2020","journal-title":"Br J Radiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-020-01469-y","article-title":"Diffusion-weighted imaging for predicting tumor consistency and extent of resection in patients with pituitary adenoma","volume":"44","author":"Ding","year":"2021","journal-title":"Neurosurg Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3171\/2023.5.JNS23179","article-title":"Clinical decision-making based on 11C-methionine PET in recurrent Cushing\u2019s disease with equivocal MRI findings","volume":"139","author":"Ishida","year":"2023","journal-title":"J Neurosurg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004244","article-title":"Usefulness of 68 ga-pentixafor PET\/CT on diagnosis and management of cushing syndrome","volume":"47","author":"Ding","year":"2022","journal-title":"Clin Nucl Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e233469","DOI":"10.1148\/radiol.233469","article-title":"Diagnostic accuracy and value of CXCR4-targeted PET\/MRI using 68Ga-pentixafor for tumor localization in cushing disease","volume":"313","author":"Wu","year":"2024","journal-title":"Radiology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1987","article-title":"Preoperative normalization of cortisol levels in Cushing\u2019s disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists","volume":"98","author":"van der Pas","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/JME-14-0011","article-title":"Somatostatin receptor ligands and resistance to treatment in pituitary adenomas","volume":"52","author":"Cuevas-Ramos","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13130420","article-title":"Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure","volume":"268","author":"Le Bihan","year":"2013","journal-title":"Radiology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2024.2249","article-title":"68Ga-DOTATOC PET\/CT in the localization of pituitary tumors in cushing\u2019s disease","volume":"40","author":"Kim","year":"2025","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1530\/EO-22-0042","article-title":"Molecular mechanisms involved in somatostatin receptor regulation in corticotroph tumors: the role of cytoskeleton and USP8 mutations","volume":"2","author":"Peverelli","year":"2022","journal-title":"Endocr Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1722034\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:22:55Z","timestamp":1769664175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1722034\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":29,"alternative-id":["10.3389\/fendo.2026.1722034"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1722034","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"1722034"}}